Table 3.
Risk Factor | HR (95% CI) | P Value |
---|---|---|
HLA match and relation | ||
Matched related donor | 1.0 | |
Matched unrelated donor | 3.798 (1.318–10.776) | .028 |
1–2 allele mismatched donor | 4.539 (1.094–11.198) | .016 |
GVHD prophylaxis, HLA match, graft source, patient age, and alemtuzumab category were included in the model selection.